Skip to main content
Clinical Trials/JPRN-UMIN000001611
JPRN-UMIN000001611
Completed
Phase 4

The prevention effect in renal disease patients taking a oral steroid with the rebamipide or the rabeprazole- a randomized control study- - The prevention effect in renal disease patients taking a oral steroid with the rebamipide or the rabeprazole- a randomized control study

Graduate School of Medicine Science, Kumamoto University0 sites50 target enrollmentJanuary 5, 2009
ConditionsRenal disease

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Renal disease
Sponsor
Graduate School of Medicine Science, Kumamoto University
Enrollment
50
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 5, 2009
End Date
March 1, 2011
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Graduate School of Medicine Science, Kumamoto University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients were excluded if patients had been malignant disease, previous upper abdominal surgery, neuropsychiatric disorder, organic brain damage, hepato\-renal disorder, cardiopulmonary disorder, symptoms suggesting or were pregnant.

Outcomes

Primary Outcomes

Not specified

Similar Trials